BioSpace News Archive

FDA

CStone Receives US FDA IND Approval for Recombinant PD-1 mAb CS1003

CStone Pharmaceuticals today announced that the United States Food and Drug Administration (FDA) has recently granted approval to the company’s Investigational New Drug (IND) application for the independently developed recombinant humanized anti-programmed death-1 (PD-1) monoclonal antibody (mAb) CS1003.

October 23, 2018
·
3 min read
Marapharm Ventures Inc. closes over-subscribed debenture and extends January 31, 2019 Warrants by one year

Marapharm Ventures Inc. wishes to announce that further to its news release on September 26, 2018, the Company has closed over-subscribed on the non-brokered unsecured debenture financing (“Debenture Offering”) through the issuance of CDN$3,263,093 principal number of debentures (the “Debentures”).

October 23, 2018
·
4 min read
Drug Development

Chi-Med Initiates a Phase I Trial of HMPL-523 in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia in China

Hutchison China MediTech Limited has initiated a Phase I study of HMPL-523, its novel spleen tyrosine kinase (“Syk”) inhibitor, in combination with azacitidine, an approved nucleoside metabolic inhibitor, in elderly patients with acute myeloid leukemia (“AML”) in China.

October 23, 2018
·
4 min read
Hitachi: Demonstration Operation of ICT System to Improve Efficiency of Energy Use and Medical Care Operations Starts at Indian Hospital

Aim to demonstrate reduction of power consumption by 30% through optimization of energy management

October 23, 2018
·
6 min read
MagForce AG to host Lunch Symposium on Local Therapies for Malignant Gliomas at the 18th European Congress of Neurosurgery (EANS2018)

MagForce AG is pleased to announce that it will host a scientific lunch symposium titled “Local Therapies for Malignant Gliomas” on Tuesday, October 23, 2018 at the 18th European Congress of Neurosurgery in Brussels, Belgium.

October 23, 2018
·
3 min read
Business

With $50 Million in Upfront Money, Takeda and Enterome Double Down on Crohn’s Disease

Two years after forging a partnership to collaborate on microbiome targets for gastrointestinal disorders, France-based Enterome SA and Takeda Pharmaceuticals have entered into a second agreement. This time with a specific focus on Crohn’s disease.

October 23, 2018
·
3 min read
·
Alex Keown
Business

With Money and Equity Changing Hands, Innate Pharma and AstraZeneca Move Deeper into an Immuno-oncology Pact

French company Innate Pharma and UK-based AstraZeneca have had a research collaboration deal in place since 2015. The two companies announced a new multi-term deal to build on that collaboration.

October 23, 2018
·
2 min read
·
Mark Terry
Job Trends

Bay Area’s Biotech Talent Crisis Puts Job Seekers in the Driver’s Seat

Johnson & Johnson’s JLABS incubator in San Francisco recently convened a meeting of biopharma industry executives. One of the hot topics for one of the panels was the competition for talent.

October 23, 2018
·
3 min read
·
Mark Terry
Genetown

Allena Pharmaceuticals Presents Preclinical Data Demonstrating Normalized Urine Uric Acid Excretion and Plasma Urate Reduction Following Treatment with ALLN-346

The data was presented in a poster session on Saturday, October 20, 2018 at the 2018 American College of Rheumatology (ACR/ARHP) Annual Meeting in Chicago, IL

October 23, 2018
·
5 min read
Business

Celgene Brings in Merck KGaA Vet as Part of an Effort to Fix Clinical Development Woes

Following several clinical disappointments and declining stock prices over the past year, Celgene tapped Alise Reicin as its new head of the company’s global clinical development unit, with a focus on mid- to late-stage therapeutics.

October 23, 2018
·
2 min read
·
Alex Keown